Hemostats and Tissue Sealants
The global Hemostats and Tissue Sealants market was valued at 2959.27 Million USD in 2021 and will grow with a CAGR of 6.25% from 2021 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Blood clotting or coagulation, is an important process that eliminates excessive bleeding when a blood vessel is damaged. Platelets and proteins work together to stop the bleeding by forming a clot over the injury. Blood clottage is one of the mechanisms that reduce the loss of blood from damaged blood vessels. Hemostats and tissue sealants are used post-surgery or traumatic injury to bind or hold external tissue (skin) as well as internal tissue (blood vessels). Some key types of hemostats and tissue sealants include fibrin sealants, collagen-based compounds, synthetic agents, and tissue adhesive glues such as hydrogels and glutaraldehyde glues. Fibrin sealants have a wide range of medical applications.The recent increase in number of out-patient surgeries is the prime driver for the growth of this market. Since these surgeries help to reduce the overall healthcare expenditure, they are increasingly being preferred by insurance payers to acquire reimbursements for their surgeries. Furthermore, as the out-patient surgeries do not require overnight stays, they are readily available to the patients.
By Market Verdors
Baxter
CR Bard
Johnson & Johnson
B.Braun
Cardinal Health
Cryolife
Neomend
Vivostat
Z-Medica
By Types
Hemostats
Tissue Sealants
By Applications
Clinical Medicine
Scientific Research
Key Indicators Analysed
Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.
Opportunities and DriversIdentifying the Growing Demands and New Technology
Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hemostats and Tissue Sealants Revenue
1.4 Market Analysis by Type
1.4.1 Global Hemostats and Tissue Sealants Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Hemostats
1.4.3 Tissue Sealants
1.5 Market by Application
1.5.1 Global Hemostats and Tissue Sealants Market Share by Application: 2022-2027
1.5.2 Clinical Medicine
1.5.3 Scientific Research
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Hemostats and Tissue Sealants Market
1.8.1 Global Hemostats and Tissue Sealants Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Hemostats and Tissue Sealants Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Hemostats and Tissue Sealants Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Hemostats and Tissue Sealants Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Hemostats and Tissue Sealants Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Hemostats and Tissue Sealants Sales Volume Market Share by Region (2016-2021)
3.2 Global Hemostats and Tissue Sealants Sales Revenue Market Share by Region (2016-2021)
3.3 North America Hemostats and Tissue Sealants Sales Volume
3.3.1 North America Hemostats and Tissue Sealants Sales Volume Growth Rate (2016-2021)
3.3.2 North America Hemostats and Tissue Sealants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Hemostats and Tissue Sealants Sales Volume
3.4.1 East Asia Hemostats and Tissue Sealants Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Hemostats and Tissue Sealants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Hemostats and Tissue Sealants Sales Volume (2016-2021)
3.5.1 Europe Hemostats and Tissue Sealants Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Hemostats and Tissue Sealants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Hemostats and Tissue Sealants Sales Volume (2016-2021)
3.6.1 South Asia Hemostats and Tissue Sealants Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Hemostats and Tissue Sealants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Hemostats and Tissue Sealants Sales Volume (2016-2021)
3.7.1 Southeast Asia Hemostats and Tissue Sealants Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Hemostats and Tissue Sealants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Hemostats and Tissue Sealants Sales Volume (2016-2021)
3.8.1 Middle East Hemostats and Tissue Sealants Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Hemostats and Tissue Sealants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Hemostats and Tissue Sealants Sales Volume (2016-2021)
3.9.1 Africa Hemostats and Tissue Sealants Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Hemostats and Tissue Sealants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Hemostats and Tissue Sealants Sales Volume (2016-2021)
3.10.1 Oceania Hemostats and Tissue Sealants Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Hemostats and Tissue Sealants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Hemostats and Tissue Sealants Sales Volume (2016-2021)
3.11.1 South America Hemostats and Tissue Sealants Sales Volume Growth Rate (2016-2021)
3.11.2 South America Hemostats and Tissue Sealants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Hemostats and Tissue Sealants Sales Volume (2016-2021)
3.12.1 Rest of the World Hemostats and Tissue Sealants Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Hemostats and Tissue Sealants Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Hemostats and Tissue Sealants Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Hemostats and Tissue Sealants Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Hemostats and Tissue Sealants Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Hemostats and Tissue Sealants Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Hemostats and Tissue Sealants Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Hemostats and Tissue Sealants Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Hemostats and Tissue Sealants Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Hemostats and Tissue Sealants Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Hemostats and Tissue Sealants Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Hemostats and Tissue Sealants Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Hemostats and Tissue Sealants Sales Volume Market Share by Type (2016-2021)
14.2 Global Hemostats and Tissue Sealants Sales Revenue Market Share by Type (2016-2021)
14.3 Global Hemostats and Tissue Sealants Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Hemostats and Tissue Sealants Consumption Volume by Application (2016-2021)
15.2 Global Hemostats and Tissue Sealants Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Hemostats and Tissue Sealants Business
16.1 Baxter
16.1.1 Baxter Company Profile
16.1.2 Baxter Hemostats and Tissue Sealants Product Specification
16.1.3 Baxter Hemostats and Tissue Sealants Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 CR Bard
16.2.1 CR Bard Company Profile
16.2.2 CR Bard Hemostats and Tissue Sealants Product Specification
16.2.3 CR Bard Hemostats and Tissue Sealants Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Johnson & Johnson
16.3.1 Johnson & Johnson Company Profile
16.3.2 Johnson & Johnson Hemostats and Tissue Sealants Product Specification
16.3.3 Johnson & Johnson Hemostats and Tissue Sealants Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 B.Braun
16.4.1 B.Braun Company Profile
16.4.2 B.Braun Hemostats and Tissue Sealants Product Specification
16.4.3 B.Braun Hemostats and Tissue Sealants Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Cardinal Health
16.5.1 Cardinal Health Company Profile
16.5.2 Cardinal Health Hemostats and Tissue Sealants Product Specification
16.5.3 Cardinal Health Hemostats and Tissue Sealants Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Cryolife
16.6.1 Cryolife Company Profile
16.6.2 Cryolife Hemostats and Tissue Sealants Product Specification
16.6.3 Cryolife Hemostats and Tissue Sealants Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Neomend
16.7.1 Neomend Company Profile
16.7.2 Neomend Hemostats and Tissue Sealants Product Specification
16.7.3 Neomend Hemostats and Tissue Sealants Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Vivostat
16.8.1 Vivostat Company Profile
16.8.2 Vivostat Hemostats and Tissue Sealants Product Specification
16.8.3 Vivostat Hemostats and Tissue Sealants Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Z-Medica
16.9.1 Z-Medica Company Profile
16.9.2 Z-Medica Hemostats and Tissue Sealants Product Specification
16.9.3 Z-Medica Hemostats and Tissue Sealants Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Hemostats and Tissue Sealants Manufacturing Cost Analysis
17.1 Hemostats and Tissue Sealants Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Hemostats and Tissue Sealants
17.4 Hemostats and Tissue Sealants Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Hemostats and Tissue Sealants Distributors List
18.3 Hemostats and Tissue Sealants Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Hemostats and Tissue Sealants (2022-2027)
20.2 Global Forecasted Revenue of Hemostats and Tissue Sealants (2022-2027)
20.3 Global Forecasted Price of Hemostats and Tissue Sealants (2016-2027)
20.4 Global Forecasted Production of Hemostats and Tissue Sealants by Region (2022-2027)
20.4.1 North America Hemostats and Tissue Sealants Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Hemostats and Tissue Sealants Production, Revenue Forecast (2022-2027)
20.4.3 Europe Hemostats and Tissue Sealants Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Hemostats and Tissue Sealants Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Hemostats and Tissue Sealants Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Hemostats and Tissue Sealants Production, Revenue Forecast (2022-2027)
20.4.7 Africa Hemostats and Tissue Sealants Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Hemostats and Tissue Sealants Production, Revenue Forecast (2022-2027)
20.4.9 South America Hemostats and Tissue Sealants Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Hemostats and Tissue Sealants Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Hemostats and Tissue Sealants by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Hemostats and Tissue Sealants by Country
21.2 East Asia Market Forecasted Consumption of Hemostats and Tissue Sealants by Country
21.3 Europe Market Forecasted Consumption of Hemostats and Tissue Sealants by Countriy
21.4 South Asia Forecasted Consumption of Hemostats and Tissue Sealants by Country
21.5 Southeast Asia Forecasted Consumption of Hemostats and Tissue Sealants by Country
21.6 Middle East Forecasted Consumption of Hemostats and Tissue Sealants by Country
21.7 Africa Forecasted Consumption of Hemostats and Tissue Sealants by Country
21.8 Oceania Forecasted Consumption of Hemostats and Tissue Sealants by Country
21.9 South America Forecasted Consumption of Hemostats and Tissue Sealants by Country
21.10 Rest of the world Forecasted Consumption of Hemostats and Tissue Sealants by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer